Efffect of the ABCC3 –211C/T polymorphism on clopidogrel responsiveness in patients with percutaneous coronary intervention

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Clinical and Experimental Pharmacology and Physiology

• Publication date

  2013-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/1440-1681.12118PMID 23692149
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel-treated Chinese patients undergoing percutaneous coronary intervention

  2013cited by this paper
• Why do metabolites circulate?

  2012cited by this paper
• Increased clopidogrel response is associated with ABCC3 expression: a pilot study.

  2012cited by this paper
• Individual variability in the disposition of and response to clopidogrel: pharmacogenomics and beyond.

  2011cited by this paper
• Systematic screening of human ABCC3 polymorphisms and their effects on MRP3 expression and function.

  2011cited by this paper
• Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia

  2011cited by this paper
• A randomized clinical study comparing double kissing crush with provisional stenting for treatment of coronary bifurcation lesions: results from the DKCRUSH-II (Double Kissing Crush versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions) trial.

  2011cited by this paper
• Functional Characterization of Multidrug Resistance-Associated Protein 3 (Mrp3/Abcc3) in the Basolateral Efflux of Glucuronide Conjugates in the Mouse Small Intestine

  2010cited by this paper
• Functional analysis of nonsynonymous single nucleotide polymorphism type ATP-binding cassette transmembrane transporter subfamily C member 3

  2008cited by this paper
• Increasing Systemic Exposure of Methotrexate by Active Efflux Mediated by Multidrug Resistance-Associated Protein 3 (Mrp3/Abcc3)

  2008cited by this paper
• Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions

  2007cited by this paper
• Randomized Comparison of a High Clopidogrel Maintenance Dose in Patients With Diabetes Mellitus and Coronary Artery Disease: Results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) Study

  2007influential reference
• Genetic variations of the ABC transporter gene ABCC3 in a Japanese population.

  2007cited by this paper
• Stent thrombosis in randomized clinical trials of drug-eluting stents.

  2007cited by this paper
• Functional analysis of the polymorphism -211C>T in the regulatory region of the human ABCC3 gene.

  2007cited by this paper
• Why is it Challenging to Predict Intestinal Drug Absorption and Oral Bioavailability in Human Using Rat Model

  2006cited by this paper
• In acute leukemia, the polymorphism -211C>T in the promoter region of the multidrug resistance-associated protein 3 (MRP3) does not determine the expression level of the gene.

  2006cited by this paper
• Short-term regulation of multidrug resistance-associated protein 3 in rat and human hepatocytes.

  2005cited by this paper
• MAPPING OF MULTIDRUG RESISTANCE GENE 1 AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN ISOFORM 1 TO 5 mRNA EXPRESSION ALONG THE HUMAN INTESTINAL TRACT

  2005cited by this paper
• Genetic polymorphisms in the multidrug resistance-associated protein 3 (ABCC3, MRP3) gene and relationship to its mRNA and protein expression in human liver.

  2004cited by this paper
• Influence of Omeprazole on Multidrug Resistance Protein 3 Expression in Human Liver

  2003cited by this paper
• Tissue Distribution and Induction of Human Multidrug Resistant Protein 3

  2002cited by this paper
• Identification of 779 genetic variations in eight genes encoding members of the ATP-binding cassette, subfamily C (ABCC/MRP/CFTR)

  2002cited by this paper
• Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane

  1999cited by this paper
• cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3) 1

  1998cited by this paper
• cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3).

  1998cited by this paper

• ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?

  2021cites this paper
• Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients

  2021cites this paper
• MASS SPECTROMETRY-BASED PERSONALIZED DRUG THERAPY.

  2020cites this paper
• DNA Methylation in Stroke. Update of Latest Advances

  2017cites this paper
• New insights in the biology of ABC transporters ABCC2 and ABCC3: impact on drug disposition

  2015cites this paper
• The association of ABCC3 promoter methylation with clopidogrel response in Chinese ischemic stroke patients.

  2014cites this paper
• Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance

  2014cites this paper
• CES1A −816C as a Genetic Marker to Predict Greater Platelet Clopidogrel Response in Patients with Percutaneous Coronary Intervention

  2014cites this paper
• Environmental Research and Public Health Pharmacokinetic and Pharmacodynamic Responses to Clopidogrel: Evidences and Perspectives

  year unknowncites this paper